MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening

Patients with type 2 diabetes (T2D) are threatened by excessive cardiovascular morbidity and mortality. While accelerated arterial stiffening may represent a critical mechanistic factor driving cardiovascular risk in T2D, specific therapies to contain the underlying diabetic arterial remodeling have...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Nucleic Acids
Autors principals: Schellinger, Isabel N., Wagenhäuser, Markus, Chodisetti, Giriprakash, Mattern, Karin, Dannert, Angelika, Petzold, Anne, Jakubizka-Smorag, Joanna, Emrich, Fabian, Haunschild, Josephina, Schuster, Andreas, Schwob, Elisabeth, Schulz, Kei, Maegdefessel, Lars, Spin, Joshua M., Stumvoll, Michael, Hasenfuß, Gerd, Tsao, Philip S., Raaz, Uwe
Format: Artigo
Idioma:Inglês
Publicat: American Society of Gene & Cell Therapy 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957025/
https://ncbi.nlm.nih.gov/pubmed/33767915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2021.02.021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars